Keywords: cenomed, presents, preclinical, data, lead, drugs, biosciences

Cenomed presents preclinical data on lead drugs

Article | 24 November 2008

Cenomed BioSciences, a majority-owned subsidiary of USA-based Abraxis BioScience, presented strong data at the annual meeting of the Society for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Abraxis

Go to company listing